N. Esters

Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease

J. Belaiche, P. Rutgeerts, A. Gossum, 2002, American Journal of Gastroenterology.

Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease

P. Rutgeerts, S. Vermeire, P. Rutgeerts, 2002, Genes and Immunity.

Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study.

K. Van Steen, P. Rutgeerts, S. Vermeire, 2003, Gastroenterology.

Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease.

J. Belaiche, P. Rutgeerts, A. Gossum, 2002 .

Transmission of CARD15 (NOD2) Variants Within Families of Patients with Inflammatory Bowel Disease

P. Rutgeerts, S. Vermeire, R. Vlietinck, 2004, American Journal of Gastroenterology.

Stratification Crohn's disease patients according to their ASCA (anti-saccharomyces cerevisiae antibodies) expression

P. Rutgeerts, S. Vermeire, M. Pierik, 2002 .

Genetic-wide scanning in a Belgian IBD population reveals novel linkages and validates previous linkages

P. Rutgeerts, S. Vermeire, R. Vlietinck, 2001 .

Infliximab (Remicade) treatment in Crohn's disease and antinuclear antibody (ANA) formation

P. Rutgeerts, S. Vermeire, G. D'Haens, 2001 .